Log in to save to my catalogue

Targeted Therapies in Pheochromocytoma and Paraganglioma

Targeted Therapies in Pheochromocytoma and Paraganglioma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_497517

Targeted Therapies in Pheochromocytoma and Paraganglioma

About this item

Full title

Targeted Therapies in Pheochromocytoma and Paraganglioma

Publisher

US: Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2022-11, Vol.107 (11), p.2963-2972

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Molecular targeted therapy plays an increasingly important role in the treatment of metastatic pheochromocytomas and paragangliomas (PPGLs), which are rare tumors but remain difficult to treat. This mini-review provides an overview of established molecular targeted therapies in present use, and perspectives on those currently under deve...

Alternative Titles

Full title

Targeted Therapies in Pheochromocytoma and Paraganglioma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_497517

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_497517

Other Identifiers

ISSN

0021-972X,1945-7197

E-ISSN

1945-7197

DOI

10.1210/clinem/dgac471

How to access this item